Dr. Olcott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
23 Isaac Street
Middleboro, MA 02346Phone+1 774-419-1000
Education & Training
Boston VA Healthcare System (Brockton-West Roxbury)/Harvard Medical SchoolResidency, Psychiatry, 2018 - 2022
UCLA Anderson School of ManagementMBA, 2016 - 2018
David Geffen School of Medicine at UCLAClass of 2018- Duke UniversityBS, Biology and Chemistry, Magna Cum Laude, Phi Beta Kappa, 2007 - 2011
Certifications & Licensure
MA State Medical License 2018 - 2025
Awards, Honors, & Recognition
- Edward V. Sedgwick III Memorial Award UCLA Anderson School of Management, 2018
Publications & Presentations
PubMed
- 36 citationsNitric Oxide–Releasing Nanoparticles Prevent Propionibacterium acnes–Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Inn...Min Qin, Angelo Landriscina, Jamie Rosen, Gabrielle Wei, Stephanie Kao
The Journal of Investigative Dermatology. 2015-11-01 - 76 citationsCOVID-19 Pandemic: Impact on psychiatric care in the United States.Ermal Bojdani, Aishwarya Rajagopalan, Anderson Chen, Priya Gearin, William Olcott
Psychiatry Research. 2020-07-01 - 45 citationsNMDA antagonists for treating the non-motor symptoms in Parkinson’s diseaseBrigitte Vanle, William Olcott, Jaime M Jimenez, Luma Bashmi, Itai Danovitch
Translational Psychiatry. 2018-06-15
Journal Articles
- NMDA antagonists for treating the non-motor symptoms in Parkinson’s diseaseBrigitte Vanle, William Olcott, Jaime Jimenez, Luma Bashmi, Itai Danovitch & Waguih William IsHak, Translational Psychiatry, 6/15/2018
- Nitric Oxide-Releasing Nanoparticles Prevent Propionibacterium acnes-Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Inn...Qin M, Landriscina A, Rosen JM, Wei G, Kao S, Olcott W, Agak GW, Paz KB, Bonventre J, Clendaniel A3, Harper S4, Adler BL2, Krausz AE, Friedman JM, Nosanchuk JD, Kim J,..., Journal of Investigative Dermatology, 7/15/2015
- PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.Park SH, Ito K, Olcott W, Katsyv I, Halstead-Nussloch G, Irie HY., Breast Cancer Research, 6/19/2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
